Copyright
©The Author(s) 2021.
World J Gastroenterol. Sep 28, 2021; 27(36): 6079-6092
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6079
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6079
Figure 4 miR-588 contributes to cisplatin resistance of gastric cancer cells.
A: Detection of cell viability by CCK-8 assay in SGC7901 cells treated with miR-588 inhibitor and exposed to cisplatin (DDP) at the indicated doses; B and C: Detection of cell apoptosis by flow cytometry in DDP-resistant SGC7901 cells co-treated with DDP and miR-588 inhibitor. Data shown are the mean ± SD, bP < 0.01. DDP: Cisplatin.
- Citation: Cui HY, Rong JS, Chen J, Guo J, Zhu JQ, Ruan M, Zuo RR, Zhang SS, Qi JM, Zhang BH. Exosomal microRNA-588 from M2 polarized macrophages contributes to cisplatin resistance of gastric cancer cells. World J Gastroenterol 2021; 27(36): 6079-6092
- URL: https://www.wjgnet.com/1007-9327/full/v27/i36/6079.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i36.6079